Iodine (131 I) derlotuximab biotin
From Infogalactic: the planetary knowledge core
| Monoclonal antibody | |
|---|---|
| Type | ? |
| Source | Chimeric (mouse/human) |
| Target | histone complex |
| Clinical data | |
| Trade names | Cotara |
| Identifiers | |
| CAS Number | 340013-96-9 |
| ATC code | none |
| Chemical data | |
| Formula | C6436H9960N1704O2022S46 |
| Molecular mass | 145.0 kg/mol |
Iodine (131 I) derlotuximab biotin is a monoclonal antibody designed for the treatment of recurrent glioblastoma multiforme.[1]
This drug was developed by Peregrine Pharmaceuticals, Inc.
References
- ↑ Statement On A Nonproprietary Name Adopted By The USAN Council - Iodine I 131 Derlotuximab Biotin, American Medical Association.
<templatestyles src="Asbox/styles.css"></templatestyles>
 |
This monoclonal antibody-related article is a stub. You can help Wikipedia by expanding it. |
Categories:
- Chemical articles having calculated molecular weight overwritten
- Drugs that are a monoclonal antibody
- Articles without EBI source
- Chemicals that do not have a ChemSpider ID assigned
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Drugs not assigned an ATC code
- Drugs with no legal status
- Articles containing unverified chemical infoboxes
- Monoclonal antibody stubs
- Monoclonal antibodies
